Utility of Alpha-Fetoprotein and Ultrasound in the Diagnosis and Prognosis of Patients with Hepatocellular Liver Cancer

References

• Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584–590. doi:10.1097/CM9.0000000000002108
   PubMed Web of Science ®Google Scholar
• Liu SS, Ma XF, Zhao J, et al. Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis. Lipids Health Dis. 2020;19(1):118. doi:10.1186/s12944-020-01288-6
   PubMed Web of Science ®Google Scholar
• Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10(11):1111–1118. doi:10.1016/S1470-2045(09)70241-4
   PubMed Web of Science ®Google Scholar
• Zhao HB. Application of medical imaging in liver cancer diagnosis. Imaging Research and Medical Application. 2019;3(4):56–57.
   Google Scholar
• Chiang JK, Chih-Wen L, Kao YH. Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study. BMJ Open. 2017;7(6):e015936. doi:10.1136/bmjopen-2017-015936
   PubMed Web of Science ®Google Scholar
• Pocha C, Dieperink E, McMaken KA, et al. Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study. Aliment Pharmacol Ther. 2013;38(3):303–312. doi:10.1111/apt.12370
   PubMed Web of Science ®Google Scholar
• Bai DS, Zhang C, Chen P, et al. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Sci Rep. 2017;7(1):12870. doi:10.1038/s41598-017-12834-1
   PubMed Web of Science ®Google Scholar
• Xie QS, Chen ZX, Zhao YJ, et al. Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis. Asian J Surg. 2021;44(1):36–45. doi:10.1016/j.asjsur.2020.08.019
   PubMed Web of Science ®Google Scholar
• Choi J, Tayob N, Lim YS. Detecting early hepatocellular carcinoma in patients with chronic hepatitis B using longitudinal α-fetoprotein screening. Clin Gastroenterol Hepatol. 2023;21(6):1590–1597. doi:10.1016/j.cgh.2022.08.018
   PubMed Web of Science ®Google Scholar
• Yen YH, Kee KM, Li WF, et al. Stationary trend in elevated serum alpha-fetoprotein level in hepatocellular carcinoma patients. Cancers (Basel). 2023;15(4):1222. doi:10.3390/cancers15041222
   PubMed Web of Science ®Google Scholar
• Hanif H, Ali MJ, Susheela AT, et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol. 2022;28(2):216–229. doi:10.3748/wjg.v28.i2.216
   PubMed Web of Science ®Google Scholar
• Hatanaka T, Arai H, Kakizaki S. Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Hepatol. 2018;10(7):485–495. doi:10.4254/wjh.v10.i7.485
   PubMedGoogle Scholar
• Liu X, Xie Y, Qi X, Xu K. Transcatheter arterial chemoembolization (TACE) with iRGD peptide in rabbit VX2 liver tumor. J Cancer Res Ther. 2020;16(7):1703–1709. doi:10.4103/jcrt.JCRT_1411_20
   PubMed Web of Science ®Google Scholar
• Zhao W, Xu J, You Y, et al. Thermoresponsive hydrogel for transcatheter arterial chemoembolization of hepatocellular carcinoma. Chem Commun. 2023;59(61):9352–9355. doi:10.1039/d3cc02257a
   PubMed Web of Science ®Google Scholar
• Wang CH, Wey KC, Mo LR, et al. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Asian Pac J Cancer Prev. 2015;16(9):3595–3604. doi:10.7314/apjcp.2015.16.9.3595
   PubMedGoogle Scholar
• Tanaka H. Current role of ultrasound in the diagnosis of hepatocellular carcinoma. J Med Ultrason. 2020;47(2):239–255. doi:10.1007/s10396-020-01012-y
   PubMed Web of Science ®Google Scholar
• Jia PF, Gao WP. Malignant liver cancer ultrasonic image processing and analysis based on MATLAB. Tissue Engineering Research and Clinical Rehabilitation. 2009;13(43):8523–8526. doi:10.3969/j.issn.1673-8225.2009.43.026
   Google Scholar
• Ren FY, Piao XX, Jin AL. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol. 2006;12(29):46564659. doi:10.3748/wjg.v12.i29.4656
   Web of Science ®Google Scholar
• Demirtas CO, Gunduz F, Tuney D, et al. Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients. Eur J Gastroenterol Hepatol. 2020;32(4):517–523. doi:10.1097/MEG.0000000000001528
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang Y, Yang N, et al. Evaluation of the combined application of AFP, AFP-L3%, and DCP for hepatocellular carcinoma diagnosis: a meta-analysis. Biomed Res Int. 2020;2020:5087643. doi:10.1155/2020/5087643
   PubMed Web of Science ®Google Scholar
• Yu M, Huang L, Zhang S, et al. Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression. Front Cell Infect Microbiol. 2023;13:1082390. doi:10.3389/fcimb.2023.1082390
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu Q, Qin Y, et al. Ordered labeling-facilitated electrochemical assay of alpha-fetoprotein-L3 ratio for diagnosing hepatocellular carcinoma. ACS Appl Mater Interfaces. 2023;15(5):6411–6419. doi:10.1021/acsami.2c19231
   PubMedGoogle Scholar
• Zhang X, Wu LN, Li XQ, et al. Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis. BMC Gastroenterol. 2023;23(1):85. doi:10.1186/s12876-023-02685-8
   PubMed Web of Science ®Google Scholar
• Bureau of Medical Administration, National Health Commission of the People’s Republic of China. [Standardization for diagnosis and treatment of hepatocellular carcinoma (2022 edition)]. Zhonghua Gan Zang Bing Za Zhi. 2022;30(4):367–388. Chinese. doi:10.3760/cma.j.cn501113-20220413-00193
   PubMedGoogle Scholar
• Urhuț MC, Săndulescu LD, Ciocâlteu A, et al. The clinical value of multimodal ultrasound for the differential diagnosis of hepatocellular carcinoma from other liver tumors in relation to histopathology. Diagnostics. 2023;13(20):3288. doi:10.3390/diagnostics13203288
   Web of Science ®Google Scholar
• Zhou JM, Wang T, Zhang KH. AFP-L3 for the diagnosis of early hepatocellular carcinoma: a meta-analysis. Medicine. 2021;100(43):e27673. doi:10.1097/MD.0000000000027673
   PubMed Web of Science ®Google Scholar